MCMaria Costantini

Maria Costantini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Costantini has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Respiratory Responses to Ozone Exposure. MOSES (The Multicenter Ozone Study in Older Subjects)

    by Mehrdad Arjomandi, John R. Balmes, Mark W. Frampton, Philip Bromberg, David Q. Rich, Paul Stark, Neil E. Alexis, Maria Costantini, Danielle Hollenbeck-Pringle, Nicholas Dagincourt, et al.

    Rationale: Acute respiratory effects of low-level ozone exposure are not well defined in older adults. Objective: The Multicenter Ozone Study in oldEr Subjects (MOSES), although primarily focused on acute cardiovascular effects, provided an opportunity to assess respiratory responses to low concentrations of ozone in older healthy adults. Methods: We performed a randomized crossover, controlled exposure study of 87 healthy adults (59.9±4.5 years old; 60% female) to 0, 70, and 120 ppb ozone for 3 hours with intermittent exercise. Outcome measures were spirometry, sputum markers of airway inflammation, and plasma club cell protein-16 (CC16), a marker of airway epithelial injury. The effects of ozone exposure on these outcomes were evaluated with mixed effect linear models. A p-value 1 and FVC increased from pre-exposure values by 2.7% (2.0, 3.4) and 2.1% (1.3, 2.9), respectively, 15 min post-exposure to filtered air (0 ppb). Exposure to ozone reduced these increases in a concentration-dependent manner. After 120 ppb exposure, FEV1 and FVC decreased by 1.7% (1.1, 2.3) and 0.8% (0.3, 1.3), respectively. A similar concentration-dependent pattern was still discernible 22 h post-exposure. At 4 h post-exposure, plasma CC16 increased from pre-exposure levels in an ozone-concentration-dependent manner. Sputum neutrophils obtained 22 h post-exposure showed a marginally significant increase in a concentration-dependent manner (p=0.012), but pro-inflammatory cytokines (IL-6, IL-8, TNFα) were not significantly affected. Conclusions: Exposure to ozone at near ambient levels induced lung function effects, airway injury, and airway inflammation in older healthy adults. Clinical trial registration available at www.clinicaltrials.gov, ID NCT01487005


  • Advanced Collaborative Emissions Study (ACES)

    by Daniel Greenbaum, Maria Costantini, Annemoon Van Erp, Rashid Shaikh, Brent Bailey, Chris Tennant, Imad Khalek, Joe Mauderly, Jacob McDonald, Barbara Zielinska, et al.

    The objective of the Advanced Collaborative Emissions Study (ACES) was to determine before widespread commercial deployment whether or not the new, energy-efficient, heavy duty diesel engines (2007 and 2010 EPA Emissions Standards Compliant) may generate anticipated toxic emissions that could adversely affect the environment and human health. ACES was planned to take place in three phases. In Phase 1, extensive emissions characterization of four production-intent prototype engine and control systems designed to meet 2007 standards for nitrogen oxides (NOx) and particulate matter (PM) was conducted at an existing emissions characterization facility: Southwest Research Institute (SwRI). One of the tested engines was selected (at random, after careful comparison of results) for health testing in Phase 3. In Phase 2, extensive emission characterization of three production-intent prototype engine and control systems meeting the 2010 standards (including more advanced NOx controls to meet the more stringent 2010 NOx standards) was conducted at the same test facility. In Phase 3, one engine/aftertreatment system selected from Phase 1 was further characterized during health effects studies (at an existing inhalation toxicology laboratory: Lovelace Respiratory Research Institute, [LRRI]) to form the basis of the ACES safety assessment. The Department of Energy (DOE) award provided funding for emissionsmore » characterization in Phases 1 and 2 as well as exposure characterization in Phase 3. The main health analyses in Phase 3 were funded separately and are not reported here.« less